Concepedia

Pia Roering

PR

8

Publications

300

Citations

8

H-Index

2011

Active since

Affiliations

University of Turku(Current)

Turku University Hospital

University of Helsinki

Tampere University Hospital

Pia Roering is an author at University of Turku specializing in pathology, medicine, and ovarian cancer.

ORCID

Top concepts

Publications per year

2011–2022

8

Publications

8

A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients

Manuela Tumiati, Sakari Hietanen, Johanna Hynninen et al. · Clinical Cancer Research · 2018 · 112 citations

18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer

Tuulia Vallius, Anniina Peter, Annika Auranen et al. · Gynecologic Oncology · 2015 · 53 citations

, , +7

ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors

Katja Kaipio, Ping Chen, Pia Roering et al. · The Journal of Pathology · 2019 · 53 citations · Full text

Snorc is a novel cartilage specific small membrane proteoglycan expressed in differentiating and articular chondrocytes

Jussi Heinonen, Hanna Taipaleenmäki, Pia Roering et al. · Osteoarthritis and Cartilage · 2011 · 20 citations · Full text

, , +9

REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker

Laura Lehtinen, Pia Vesterkvist, Pia Roering et al. · PLoS ONE · 2016 · 19 citations · Full text

, , +13

Rows per page

1–5 of 8